What question did this study set out to answer?

The study aims to explore AC1 inhibition as a potential target for addressing opioid tolerance and withdrawal effects.

April 10, 2026British Journal of Pharmacology0 citations

Inhibition of adenylyl cyclase 1 or exchange protein activated by cAMP restores ATP‐sensitive potassium channel activity after chronic opioid exposure

AKAmanda H. Klein SAS. M. Sabbir AlamPurdue University West Lafayette KJKelli JohnsonXavier University of Louisiana

Key Points

The study aims to explore AC1 inhibition as a potential target for addressing opioid tolerance and withdrawal effects.
Investigated the role of adenylyl cyclase 1 (AC1) in opioid signaling.
Assessed the impact of EPAC activity on potassium channel function.
Analyzed changes in potassium channel activity in response to chronic opioid exposure.
Inhibition of AC1 increased EPAC activity.
Restoration of ATP-sensitive potassium channel activity was observed after chronic opioid exposure.
Improvements in potassium channel function suggest potential pathways for mitigating opioid tolerance.

Abstract

This study presents evidence for investigating further AC1 signalling as a target for opioid tolerance and withdrawal, by increasing EPAC activity and affecting potassium channels downstream of opioid receptors.

Ask AI

Helpful

Bookmark

View Full Paper